| 发明名称 |
INHALABLE MEDICAMENT |
| 摘要 |
The present invention provides a solution formulation for inhalation comprising: a liquid phase; an active ingredient containing a carboxylic ester in which the oxygen atom is covalently bound to a quaternary nitrogen-containing heterocycle, dissolved in the liquid phase; and a magnesium or calcium salt, dissolved in the liquid phase. The formulation is particularly suited to pMDIs and nebulisers. |
| 申请公布号 |
US2016243241(A1) |
申请公布日期 |
2016.08.25 |
| 申请号 |
US201615145195 |
申请日期 |
2016.05.03 |
| 申请人 |
Teva Branded Pharmaceutical Products R&D, Inc. |
发明人 |
DALVI Mukul;WU Libo |
| 分类号 |
A61K47/12;A61K9/00;A61K47/02;A61M11/00;A61K47/06;A61K47/10;A61M15/00;A61K9/08;A61K31/46 |
主分类号 |
A61K47/12 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A solution formulation for inhalation comprising:
a liquid phase; an active ingredient containing a carboxylic ester in which the oxygen atom is covalently bound to a quaternary nitrogen-containing heterocycle, dissolved in the liquid phase; and a magnesium salt, dissolved in the liquid phase. |
| 地址 |
Frazer PA US |
